#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung Immune-mediated renal disorder Astrocytoma malignant Arteriovenous malformation Idiopathic intracranial hypertension Marfan's syndrome Myelodysplastic syndrome with excess blasts Breast cancer metastatic Cardiomyopathy Arrhythmogenic right ventricular dysplasia Cerebellar ataxia Anti-HLA antibody test positive Immune-mediated myositis Epidermolysis bullosa Exudative retinopathy More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Life with Disease Ocular melanoma Alport’s syndrome – Treatment SAPHO syndrome – Trials in Disease Optic glioma – Treatment Hepatic angiosarcoma Biotinidase deficiency – Treatment Choroid melanoma – Diagnostics Ehlers-Danlos syndrome – Basic Information Phenylketonuria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-PHENYLALANINE Jk08 Obexelimab Sparsentan Piperacillin DAPIGLUTIDE Fosamprenavir Calcium Dabrafenib Mesylate Rondaptivon Pegol Rbp030.2 Nebivolol Hydrochloride Calcitriol Elamipretide Trihydrochloride Ertugliflozin AMLENETUG Oteracil Azelastine GSKVX000000040033 Bempikibart Etifoxine Hydrochloride More therapies…

    Learn about Your Condition

    Diffuse large B-cell lymphoma Lichen planus Pleural mesothelioma malignant Cluster headache Hepatorenal syndrome Drug use disorder Ovarian granulosa cell tumour Follicular lymphoma stage II Small for dates baby HER2 negative breast cancer Neurofibrosarcoma Thyroid cancer Pancreatitis acute Congenital pseudarthrosis Obstructive pancreatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinal vein occlusion
    Investigated Drugs:
    • Aflibercept
    France

  • Study on Faricimab and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration Receiving Frequent Aflibercept Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Faricimab
    • Aflibercept
    Austria

  • Study of AAVB-081 and Prednisolone for Patients with Usher Syndrome Type 1B Retinitis Pigmentosa

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Usher’s syndrome
    • Retinitis pigmentosa
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 8 Containing The 3′-Myo7A Gene Coding Sequence
    • Adeno-Associated Viral Vector Serotype 8 Containing The 5′-Myo7A Gene Coding Sequence
    • Prednisolone
    Italy

  • Study Comparing Bimatoprost Eye Drops with Lumigan for Patients with Chronic Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    Italy

  • Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    • Aflibercept
    France Germany Hungary Italy Spain

  • Study on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Lasn01
    • Water For Injection
    • Sodium Chloride
    Germany Spain
Previous Page
1 … 25 26 27 28 29 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!